Pharma
1 min read

Indian firm Panacea says aiming to make COVID-19 vaccine

Panacea's shares jumped 20% in morning trading on India's National Stock Exchange after the news.

Reuters

Updated On Jun 10, 2020 at 12:31 PM IST

BENGALURU - Indian biotech firm Panacea Biotec Ltd said on Wednesday it would partner with U.S.-based Refana Inc to make a potential vaccine for COVID-19.

The collaboration aims to make more than 500 million doses of the vaccine candidate, with over 40 million doses expected to be available early next year, Panacea said in a statement to stock exchanges.

Panacea's shares jumped 20% in morning trading on India's National Stock Exchange after the news.

(Reporting by Sachin Ravikumar; Editing by Shailesh Kuber)